Infectious source factors affecting the severity of sexually transmitted acute hepatitis due to hepatitis B virus genotype C

Intervirology

Volumn 48, Issue 2-3, 2005, Pages 112-119

  Michitaka, Kojiro ^a   Horiike, Norio ^a   Chen, Yan ^a   Yatsuhashi, Hiroshi ^f   Yano, Michitami ^e   Kojima, Naohiko ^b   Ohkubo, Keiji ^b   Tanaka, Yosikazu ^c   Yamamoto, Kazuhisa ^d   Ohno, Naofumi ^e   Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ohzu Central Hospital   (Japan)

^c EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d Matsuyama Shimin Hospital   (Japan)

^e Internal Medicine   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

Acute hepatitis; Core promoter mutation; Fulminant hepatitis; Hepatitis B virus; Infectious source; Precore mutation; Sexual transmission

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIBODY; HEPATITIS B ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ACUTE HEPATITIS; ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENOTYPE; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTHROMBIN TIME; RISK FACTOR; SEQUENCE HOMOLOGY; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; STATISTICAL SIGNIFICANCE; VIRUS GENE; ACUTE DISEASE; AGE; BLOOD; CHEMISTRY; CLASSIFICATION; DISEASE TRANSMISSION; DNA SEQUENCE; GENETICS; HEPATITIS B; IMMUNOLOGY; ISOLATION AND PURIFICATION; JAPAN; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POINT MUTATION; VIROLOGY;

HEPATITIS B VIRUS;

ACUTE DISEASE; ADULT; AGE FACTORS; ALANINE TRANSAMINASE; BASE SEQUENCE; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; JAPAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POINT MUTATION; PROMOTER REGIONS (GENETICS); RISK FACTORS; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SEXUALLY TRANSMITTED DISEASES, VIRAL;

EID: 23844501735     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081737     Document Type: Article

References (49)

1. Eto T, Shiraki K: National project on the prevention of mother-to-infant infection by hepatitis B virus in Japan. Acta Paediatr Jpn 1989;31:681-684.
2. Japanese Red Cross Non-A, Non-B Hepatitis Research Group: Effect of screening for hepatitis C virus antibody and hepatitis B core antibody on incidence of post-transfusion hepatitis. Lancet 1991;338:1040-1041.
3. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions: Infectious disease testing for blood transfusions. JAMA 1995;274:1374-1379.
4. Struve J, Giesecke J, Lindh G, Weiland O: Heterosexual contact as a major route for transmission of acute hepatitis B among adults. J Infect 1990;20:111-121.
5. Hou MC, Wu JC, Sheng WY, Chen TZ, Lee SD, Lo KJ: Heterosexual transmission as the most common route of acute hepatitis B virus infection among adults in Taiwan - the importance of extending vaccination to susceptible adults. J Infect Dis 1993;167:938-941.
6. Bath GE, Scott TG, Sibbald CJ, Upton PA, Ramsay CN, Willocks LJ: Acute hepatitis B in Edinburgh 1975-92: A retrospective study in a population where human immunodeficiency virus is highly prevalent. Epidemiol Infect 1997;119:85-89.
7. Massari V, Maison P, Desenclos JC, Flahault A: Six years of sentinel surveillance of hepatitis B in general practice in France. Eur J Epidemiol 1998;14:765-767.
8. Lindh M, Horal P, Norkrans G: Acute hepatitis B in Western Sweden - genotypes and transmission routes. Infection 2000;28:161-163.
9. Arima S, Michitaka K, Horiike N, Kawai K, Matsubara H, Nakanishi S, Abe M, Hasebe A, Tokumoto Y, Yamamoto K, Onji M: Change of acute hepatitis B transmission routes in Japan. J Gastroenterol 2003;38:772-775.
10. Bernuau J, Rueff B, Benhamou JP: Fulminant and subfulminant liver failure: Definitions and causes. Semin Liver Dis 1986;6:97-106.
11. Robert A, Chazouilleres O: Prothrombin time in liver failure: Time, ratio, activity percentage or international normalized ratio? Hepatology 1996;24:1392-1394.
12. Takahashi Y, Shimizu M, Study Group of Fulminant Hepatitis: Aetiology and prognosis of fulminant hepatitis in Japan: A multicentre study. J Gastroenterol Hepatol 1991;6:159-164.
13. Kaplan PM, Greenman RL, Gerin JL, Purcell RH, Robinson WS: DNA polymerase associated with human hepatitis B antigen. J Virol 1973;12:995-1005.
14. Chen Y, Michitaka K, Matsubara H, Yamamoto K, Horiike N, Onji M: Complete genome sequence of hepatitis B virus (HBV) from a patient with fulminant hepatitis without precore and core promoter mutations: Comparison with HBV from a patient with acute hepatitis infected from the same infectious source. J Hepatol 2003;38:84-90.
15. Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Mukaide M, Robertson BH: Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 1999;450:66-71.
16. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M: Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991;324:1699-1704.
17. Carman WF, Fagan EA, Hadziyannis S, Karayiannis P, Tassopoulos NC, Williams R, Thomas HC: Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology 1991;14:219-222.
18. Liang TJ, Hasegawa K, Rimon N, Wands J, Ben-Porath E: A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991;324:1705-1709.
19. Kosaka Y, Takase K, Kojima M, Shimizu M, Inoue K, Yoshiba M, Tanaka S, Akahane Y, Okamoto H, Tsuda F, Miyazawa Y, Mayumi M: Fulminant hepatitis B: Induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 1991;100:1087-1094.
20. Sato S, Suzuki K, Akahane Y, Akamatsu K, Akiyama K, Yunomura K, Tsuda F, Tanaka T, Okamoto H, Miyakawa Y, Mayumi M: Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995;122:241-248.
21. Teo EK, Ostapowicz G, Hussain M, Lee WM, Fontana R, Lok AS, US ALF Study Group: Hepatitis B infection in patients with acute liver failure in the United States. Hepatology 2001;33:972-976.
22. Lamberts C, Nassal M, Velhagen I, Zentgraf H, Schroder CH: Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis. J Virol 1993;67:3756-3762.
23. Baumert TF, Rogers SA, Hasegawa K, Liang TJ: Two core promoter mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 1996;98:2268-2276.
24. Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH: Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996;70:5845-5851.
25. Kidd-Ljunggren K, Oberg M, Kidd AH: Hepatitis B virus X gene 1751 to 1764 mutations: Implications for HBeAg status and disease. J Gen Virol 1997;78:1469-1478.
26. Sterneck M, Kalinina T, Gunther S, Fischer L, Santantonio T, Greten H, Will H: Functional analysis of HBV genomes from patients with fulminant hepatitis. Hepatology 1998;28:1390-1397.
27. Kawai K, Horiike N, Michitaka K, Onji M: The effects of hepatitis B virus core promoter mutations on hepatitis B core antigen distribution in hepatocytes as detected by laser-assisted microdissection. J Hepatol 2003;38:635-641.
28. Feray C, Gigou M, Samuel D, Bernuau J, Bismuth H, Brechot C: Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. J Hepatol 1993;18:119-122.
29. Laskus T, Rakela J, Nowicki M, Persing DH: Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology 1995;109:1618-1623.
30. Hsu HY, Chang MH, Lee CY, Hsieh KH, Ni YH, Chen PJ, Chen DS: Precore mutant of hepatitis B virus in childhood fulminant hepatitis B: An infrequent association. J Infect Dis 1995;171:776-781.
31. Sterneck M, Gunther S, Santantonio T, Fischer L, Broelsch CE, Greten H, Will H: Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation. Hepatology 1996;24:300-306.
32. Karayiannis P, Alexopoulou A, Hadziyannis S, Thursz M, Watts R, Seito S, Thomas HC: Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: Importance of host factors. Hepatology 1995;22:1628-1634.
33. Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T, Okanoue T, Yotsuyanagi H, Iino S: A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Hepatology 2001;33:218-223.
34. Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, Kanda T, Fukai K, Kato M, Saisho H: Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003;37:19-26.
35. Chan HL, Hussain M, Lok AS: Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology 1999;29:976-984.
36. Blackberg J, Kidd-Ljunggren K: Genotypic differences in the hepatitis B virus core promoter and precore sequences during seroconversion from HBeAg to anti-HBe. J Med Virol 2000;60:107-112.
37. Mayerat C, Mantegani A, Frei PC: Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepat 1999;6:299-304.
38. Swenson PD, Van Geyt C, Alexander ER, Hagan H, Freitag-Koontz JM, Wilson S, Norder H, Magnius LO, Stuyver L: Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA. J Med Virol 2001;64:305-311.
39. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, Okita K, Okanoue T, Iino S, Tanaka E, Suzuki K, Watanabe H, Hige S, Mizokami M: Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 2001;34:590-594.
40. Beath SV, Boxall EH, Watson RM, Tarlow MJ, Kelly DA: Fulminant hepatitis B in infants born to anti-HBe hepatitis B carrier mothers. BMJ 1992;304:1169-1170.
41. Terazawa S, Kojima M, Yamanaka T, Yotsumoto S, Okamoto H, Tsuda F, Miyakawa Y, Mayumi M: Hepatitis B virus mutants with precore-region defects in two babies with fulminant hepatitis and their mothers positive for antibody to hepatitis B e antigen. Pediatr Res 1991;29:5-9.
42. Vanclaire J, Cornu C, Sokal EM: Fulminant hepatitis B in an infant born to a hepatitis Be antibody positive, DNA negative carrier. Arch Dis Child 1991;66:983-985.
43. Komatsu H, Inui A, Morinishi Y, Sogo T, Fujisawa T: Sequence analysis of hepatitis B virus genomes from an infant with acute severe hepatitis and a hepatitis B e antigen-positive carrier mother. J Med Virol 2001;65:457-462.
44. Cacciola I, Cerenzia G, Pollicino T, Squadrito G, Castellaneta S, Zanetti AR, Mieli-Vergani G, Raimondo G: Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. J Hepatol 2002;36:426-432.
45. Aye TT, Uchida T, Becker SO, Shikata T, Mima S: Completely or nearly identical hepatitis B virus strains replicate between patients with acute or fulminant hepatitis B and their respective infectious sources. J Med Virol 1994;42:60-65.
46. Yotsumoto S, Kojima M, Shoji I, Yamamoto K, Okamoto H, Mishiro S: Fulminant hepatitis related to transmission of hepatitis B variants with precore mutations between spouses. Hepatology 1992;16:31-35.
47. Tanaka S, Yosiba M, Iino S, Fukuda M, Nakao H, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M: A common-source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutant. Kidney Int 1995;48:1972-1978.
48. Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology 2001;34:1225-1241.
49. Kobayashi M, Koike K: Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. Gene 1984;30:227-232.